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Introduction and management question 
Acute hyperammonaemia in children is associated with poor neurological outcomes and high 
mortality. As theses outcomes are inversely correlated to the duration of the hyperammonaemic 
coma, prompt management with conservative treatment with/without renal replacement therapy is 
needed. Cardio-Renal Pediatric Dialysis Emergency CRRT Machine (CarpeDiem) is demonstrated a safe 
and effective CRRT machine in neonates and infants. Experience on its use in acute hyperammonaemia 
is limited.  
As neurological outcomes are related to the duration of the hyperammonaemic coma, management 
should aim to decrease serum ammonia levels below 400 µmol/L in a short period of time (ideally less 
than 4 hours). Therefore, we formulated the following management question in our unit:  
“How efficient can CARPEDIEM CRRT machine decrease serum ammonia levels in comparison to 4008 
Fresenius machine? How can we safely incorporate CARPEDIEM in our local protocol using a kinetic-
based approach, ensuring a decrease in serum ammonia below 400 µmol/L in less than 4 hours ?”  
Methods  
To answer this management question, we reviewed four patients who were treated with hemodialysis 
between 2019-2020 with different dialysis machines, i.e. either hemodialysis (HD) with the 4008 
machine and FX Paed dialyzer (Fresenius Medical Care, Bad Homburg, Germany), and/or continuous 
veno-venous hemodialysis (CVVHD) with the CarpeDiem machine and the 0.15m² or the 0.25m² 
dialyzer (Medtronic, Minnesota, USA).  
Dialyzer clearance, and with it, dialyzer extraction ratio was derived from the ammonia concentration-
time curves during dialysis, in the four tested patients. Ammonia was hereby assumed being 
distributed in a single compartment in the patient of 60% of total body weight. Serum ammonia level 
was thus expected to follow an exponential decline during dialysis. Generation was derived from the 
concentration increase in the interdialytic interval, assuming the patients to be in a rather steady state 
during the time period of calculation. Single compartmental models for an average child of 2, 3, 4 and 
5kg were further used to simulate ammonia concentration for different ammonia start concentrations 
(i.e. 3000, 1500, 800, 400, and 200µmol/L), dialysis machines/dialyzers and different dialysis settings 
(i.e. blood flow QB of 30-50mL/min).  
Results 
The four patients (3.24±0.40 kg) underwent 13 dialyses, i.e. 5 with the 4008-FXPaed, and 8 with the 
CarpeDiem of which 4 with the 0.15m² and 4 with the 0.25m² dialyzer. Blood flows were 30-35mL/min 
(4008-FXPaed), 22-35mL/min (Carpe Diem 0.15), and 30-34mL/min (Carpe Diem 0.25).  
Extraction ratios were 38±5% in the FXPaed on the 4008 dialysis machine, 10±3% and 13±3% in the 
0.15m² and 0.25m² dialyzer, respectively on the CarpeDiem. Generation was 0.40±0.25µmol/min, 
having no impact on the calculation of dialyzer clearance and extraction ratio. 
For a start concentration of 3000µmol/L in a patient of 3kg, the time to reach the target of 400µmol/L 
was, with the 4008-FXPaed, 315 and 190min for a QB of 30 and 50mL/min, respectively, while it was 
205 and 125min for a start concentration of 1500µmol/L, and 110 and 65min for a start concentration 
of 800µmol/L. The CarpeDiem machine was found inadequate to decrease ammonia concentrations 
within 4h for start concentrations higher than 800µmol/L. Simulations in a patient of 5kg resulted in 
longer time intervals to reach the target for the 4008-FXPaed, while targets cannot be reached within 
4h with the CarpeDiem.  
Based on the results of these simulations, a local protocol for acute hyperammonaemia was developed 
aiming to reach serum ammonia levels below 400µmol/L within 4 hours after diagnosis, and a serum 
ammonia level below 200µmol/L within the following 4 hours. Taking into account these management 
goals, Carpe Diem was incorporated in our local protocol as first line renal replacement therapy in 
neonates presenting with a hyperammonaemic coma and serum ammonia levels between 200-
400µmol/L. In neonates presenting with ammonia levels higher than 400µmol/L, Fresenius 4008 
machine (QB 50mL/min) was used as first line treatment until serum ammonia levels dropped below 
200µmol/L. At this point Fresenius 4008 was switched to CarpeDiem to avoid rebound of serum 
ammonia levels.  
Conclusion 
Kinetic models can guide our management decisions and treatment protocols by predicting which 
treatment goals can be reached with a particular dialysis prescription, available resources and/or 
dialysis modality.  
 
 
 
